glp-1 neuropathy Can a New Drug Lessen Pain From Peripheral Neuropathy? Glucagon-like peptide-1 (GLP-1) receptor agonists
Description
David, L
FDA-approved oral GLP-1 therapies are drugs, not wellness products
It contains the active ingredient semaglutide
Glucagon receptors increase energy expenditures with direct effects on hepatic fat metabolism, which reduces serum lipids and liver fats
The changes build on CVS Caremarks efforts as a pharmacy benefits manager to improve access to FDA-approved weight management therapies at more affordable costs
